Free Trial

Qualigen Therapeutics (QLGN) SEC Filings & 10K Form

Qualigen Therapeutics logo
$3.87 +0.01 (+0.26%)
(As of 11/20/2024 ET)

Recent Qualigen Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
3:25 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
4:10 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
3:55 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
4:06 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/22/2024
3:35 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:05 PM
Braeden Lichti (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
3:10 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form DEFA14A
10/09/2024
3:10 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
4:10 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:15 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
2:46 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 424B4
09/05/2024
8:25 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
11:15 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form EFFECT
08/22/2024
3:41 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1/A
08/09/2024
5:15 AM
BECHER CAMPBELL (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:28 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1/A
07/25/2024
10:57 AM
PRICE CODY (Reporting)
Qualigen Therapeutics, Inc. (Issuer)
Qualigen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
4:00 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
8:47 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form PRE 14A
07/15/2024
4:06 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:15 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
4:25 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
2:35 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:05 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form NT 10-Q
05/03/2024
7:59 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form S-1/A
05/02/2024
11:15 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form EFFECT
04/05/2024
8:59 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
1:35 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form NT 10-K
03/28/2024
3:05 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:00 AM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
3:30 PM
Qualigen Therapeutics, Inc. (Filer)
Qualigen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:QLGN) was last updated on 11/20/2024 by MarketBeat.com Staff
From Our Partners